Literature DB >> 16083221

Determination of reference intervals of HbA1C (DCCT/NGSP) and HbA1C (IFCC) in adults.

Navapun Charuruks1, Anna Milintagas, Phandee Watanaboonyoungcharoen, Chomsri Ariyaboonsiri.   

Abstract

OBJECTIVE: To establish HbA1C reference intervals according to DCCT/NGSP (HbA1C DCCT/NGSP) and IFCC (HbA1C IFCC) in adults. STUDY
DESIGN: The study was a descriptive study. MATERIAL AND
METHOD: The study was done in 144 subjects, with 99 males and 45 females, aged between 19 to 78 years old. All subjects had normal vital signs, physical examination, chest X-ray. Subjects who had hyperglycemia, renal problem, liver problem, anemia, and/or hemoglobinopathy were excluded from the present study.
RESULTS: Reference intervals of HbA1C (DCCT/NGSP) is 5.47% (4.79-6.15) and HbA1C (IFCC) is 3.66% (2.88-4.44). The authors also found very high correlation between HbA1C (DCCT/NGSP) and HbA1C (IFCC) of total, male, female, < 35 years old, and > or = 35 years old, r = 0.9995, 09997, 0.9992, 0.9988, and 0.9999, respectively.
CONCLUSION: The authors found that HbA1C (DCCT/NGSP) and HbA1C (IFCC) are not affected by sex but are influenced significantly by age group. Since HbA1C (IFCC) will be widely used in routine diabetes management, the authors recommend all laboratories provide the results of HbA1C in both DCCT/NGSP and IFCC methods during this interim period.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16083221

Source DB:  PubMed          Journal:  J Med Assoc Thai        ISSN: 0125-2208


  2 in total

1.  Determinants of Self-Care in Diabetic Patients Based on Health Belief Model.

Authors:  Abbasali Dehghani-Tafti; Seyed Saeid Mazloomy Mahmoodabad; Mohammad Ali Morowatisharifabad; Mohammad Afkhami Ardakani; Hassan Rezaeipandari; Mohammad Hassan Lotfi
Journal:  Glob J Health Sci       Date:  2015-02-24

2.  Hemoglobin A1c Levels Are Slightly but Significantly Lower in Normoglycemic Subjects With the Hemoglobin E Phenotype.

Authors:  Busadee Pratumvinit; Kanit Reesukumal; Sithikan Hanyongyuth; Sujitra Wangchaijaroenkit; Julaporn Pooliam; Gerald J Kost; Panumas Kamkang; Tze Ping Loh
Journal:  Ann Lab Med       Date:  2019-03       Impact factor: 3.464

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.